Clinical meaning
Controlled substances exert their effects through specific neuroreceptor systems: opioids bind mu, kappa, and delta receptors in the central nervous system modulating pain perception and reward pathways via endogenous endorphin circuits. Benzodiazepines enhance gamma-aminobutyric acid (GABA) activity at GABA-A receptors by increasing chloride channel opening frequency, producing anxiolytic, sedative, and anticonvulsant effects. Stimulants such as amphetamines and methylphenidate increase synaptic dopamine and norepinephrine concentrations by blocking reuptake transporters and, in the case of amphetamines, promoting vesicular release. Tolerance develops through receptor downregulation and desensitization, while physical dependence involves neuroadaptive changes that produce withdrawal symptoms upon abrupt discontinuation, necessitating structured tapering protocols.